XML 51 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Net Cash Provided by (Used in) Operating Activities [Abstract]    
Net income $ 32,331 $ 41,066
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,169 5,525
Share-based compensation 4,990 4,210
Amortization of capitalized software 1,517 972
Provision for losses on accounts receivable 600 1,306
Litigation reserve, including interest expense 3,700 0
Gain (Loss) on Sale of Property Plant Equipment 0 (41)
Changes in operating assets and liabilities (net of impact of acquisitions):    
Decrease (increase) in accounts receivable 144 (5,957)
Increase in inventory (4,082) (3,828)
Increase in prepaid expenses and other assets (12,851) (9,033)
Decrease in accounts payable (2,803) (7,327)
Decrease in accrued expenses and other current liabilities (10,074) (30,379)
Increase (decrease) in income tax assets and liabilities 7,863 (8,954)
Increase in deferred revenue 22,503 18,462
Net cash flows provided by operating activities 49,007 6,022
Cash flows from investing activities:    
Proceeds from maturities of investments 39,369 16,553
Purchases of investments (46,375) (4,029)
Purchases of property, plant and equipment (10,968) (3,796)
Internally developed software costs (2,028) (850)
Other 0 (86)
Net cash flows (used in) provided by investing activities (20,002) 7,792
Cash flows from financing activities:    
Repurchases of common stock (91,603) (13,165)
Proceeds from stock option exercises 10,137 4,364
Principal payments on lines of credit (1,795) 0
Realized tax benefits from stock option exercises 886 1,370
Other (33) (26)
Net cash flows used in financing activities (82,408) (7,457)
Effect of exchange rate changes on cash and cash equivalents 7,313 4,885
Net (decrease) increase in cash and cash equivalents (46,090) 11,242
Cash and cash equivalents at beginning of period 486,023 562,786
Cash and cash equivalents at end of period $ 439,933 $ 574,028